Sonoma Pharmaceuticals, Inc. (SNOA) Financials

SNOA Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 14.0 million 10.9 million
Dec. 31, 2025 13.6 million 10.2 million
Sept. 30, 2025 13.9 million 10.1 million
June 30, 2025 14.6 million 10.5 million

SNOA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -548000 135000
Dec. 31, 2025 -811000 -27000
Sept. 30, 2025 -142000 90000
June 30, 2025 -2.1 million 57000

SNOA Net Income

No data available :(

SNOA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 2.4 million - 620000
Dec. 31, 2025 2.6 million - 655000
Sept. 30, 2025 3.0 million - 479000
June 30, 2025 3.6 million - 536000

SNOA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 1.8 million
Dec. 31, 2025 1.7 million
Sept. 30, 2025 1.6 million
June 30, 2025 1.6 million

SNOA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 29000 545000 2.0 million -
Dec. 31, 2025 47000 557000 1.8 million -
Sept. 30, 2025 47000 575000 1.9 million -
June 30, 2025 106000 594000 2.0 million -

SNOA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 5.6 million 3.4 million
Dec. 31, 2025 4.3 million 2.7 million
Sept. 30, 2025 5.6 million 3.5 million
June 30, 2025 4.0 million 2.6 million

SNOA Revenue by Segment
Graph available only for paid members. Upgrade to see it.

SNOA

Price: $1.17

52 week price:
0.85
6.92

Earnings Per Share: -1.89 USD

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 313242

Ebitda: -12.7 million

Market Capitalization: 5.6 million

Links: